SteadyMed Reports Recent Developments, Financial Highlights and First Quarter 2015 Financial Results
14. Mai 2015 07:39 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., May 14, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases...
SteadyMed Submits Application for Orphan Drug Designation for Trevyent(R) For Pulmonary Arterial Hypertension
07. Mai 2015 07:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY) a specialty pharmaceutical company, today announced that it has submitted an application to the U.S. Food and Drug...
SteadyMed Granted Additional U.S. Patent With Patent Term Extension
22. April 2015 07:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY) a specialty pharmaceutical company, today announced the issuance of a new patent from the United States Patent and...
SteadyMed Appoints David W. Nassif as Its Full Time Executive Vice President and Chief Financial Officer
08. April 2015 07:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company, today announced the appointment of David W. Nassif as its full time Executive...
SteadyMed Announces Closing of Initial Public Offering
25. März 2015 14:26 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the closing of its initial public offering of 4,700,000 ordinary shares at a...
SteadyMed Announces Pricing of Initial Public Offering
20. März 2015 07:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 20, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the pricing of its initial public offering of 4,700,000 ordinary shares at a...
SteadyMed Ltd. Launches Initial Public Offering
09. März 2015 16:01 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the launch of its initial public offering of 4,250,000 ordinary shares at an...
SteadyMed Raises $12.2 Million in Equity Financing
29. Januar 2015 08:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address...